Precision Biosciences (DTIL) Shareholder's Equity Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.25% |
| Dec 31, 2025 | 63.58% |
| Sep 30, 2025 | -74.36% |
| Jun 30, 2025 | -54.42% |
| Mar 31, 2025 | 32.60% |
| Dec 31, 2024 | 198.99% |
| Sep 30, 2024 | 123.19% |
| Jun 30, 2024 | 119.48% |
| Mar 31, 2024 | -7.39% |
| Dec 31, 2023 | -68.79% |
| Sep 30, 2023 | -65.56% |
| Jun 30, 2023 | -66.96% |
| Mar 31, 2023 | -42.32% |
| Dec 31, 2022 | -33.71% |
| Sep 30, 2022 | -16.82% |
| Jun 30, 2022 | 2.46% |
| Mar 31, 2022 | 18.42% |
| Dec 31, 2021 | 105.22% |
| Sep 30, 2021 | 58.94% |
| Jun 30, 2021 | 17.47% |
| Mar 31, 2021 | -48.87% |
| Dec 31, 2020 | -67.88% |
| Sep 30, 2020 | -59.03% |
| Jun 30, 2020 | -50.80% |
| Mar 31, 2020 | 962.18% |
| Dec 31, 2019 | 246.13% |
| Sep 30, 2019 | 190.73% |
| Jun 30, 2019 | 323.24% |
| Mar 31, 2019 | 130.76% |